These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 8727349)

  • 1. [Multiple myeloma associated with phenytoin (diphenylhydantoin) therapy].
    Kanoh T; Dobashi H; Inada T
    Rinsho Ketsueki; 1996 Mar; 37(3):239-43. PubMed ID: 8727349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphoproliferative disorders in four patients receiving chronic diphenylhydantoin therapy: etiologic correlation or chance association?
    Matzner Y; Polliack A
    Isr J Med Sci; 1978 Aug; 14(8):865-9. PubMed ID: 700999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal gammopathy and subsequent multiple myeloma in a patient on chronic diphenylhydantoin therapy.
    Matzner Y; Polliack A
    Isr J Med Sci; 1978 Dec; 14(12):1265-7. PubMed ID: 748238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myelomatosis after phenytoin therapy: a chance association?
    Matzner Y; Polliack A
    Scand J Haematol; 1978 Oct; 21(4):309-12. PubMed ID: 103187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Angioblastic lymphadenopathy--its course and prognosis].
    Mihaljević B; Jancić-Nedeljkov R; Janković S; Milivojević G; Cemerikić-Martinović V; Jovanović V; Colović M; Petrović M
    Srp Arh Celok Lek; 1999; 127(11-12):376-82. PubMed ID: 10686819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary systemic amyloidosis with delayed progression to multiple myeloma.
    Rajkumar SV; Gertz MA; Kyle RA
    Cancer; 1998 Apr; 82(8):1501-5. PubMed ID: 9554527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenytoin hypersensitivity syndrome.
    Sanders DY; Thompson JR; Carlton FB
    J Miss State Med Assoc; 1996 Feb; 37(2):471-5. PubMed ID: 9053530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple myeloma after phenytoin therapy.
    Aymard JP; Lederlin P; Witz F; Colomb JN; Faure G; Guerci O; Herbeuval R
    Scand J Haematol; 1981 Apr; 26(4):330-2. PubMed ID: 7336147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple myeloma arising from monoclonal gammopathy of undetermined significance in a patient with Gaucher's disease.
    Brady K; Corash L; Bhargava V
    Arch Pathol Lab Med; 1997 Oct; 121(10):1108-11. PubMed ID: 9341594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IgM myeloma: a report of four cases.
    Dierlamm T; Laack E; Dierlamm J; Fiedler W; Hossfeld DK
    Ann Hematol; 2002 Mar; 81(3):136-9. PubMed ID: 11904738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toxicology and Carcinogenesis Studies of 5,5-Diphenylhydantoin (CAS No. 57-41-0) (Phenytoin) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Nov; 404():1-303. PubMed ID: 12621514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Neurologic sequelae of bone changes in multiple myeloma and its therapy].
    Basić-kes V; Basić-Jukić N; Kes P; Demarin V; Labar B
    Acta Med Croatica; 2002; 56(3):103-7. PubMed ID: 12630341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenytoin: effective but insidious therapy for epilepsy in people with intellectual disability.
    Iivanainen M
    J Intellect Disabil Res; 1998 Dec; 42 Suppl 1():24-31. PubMed ID: 10030428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple myeloma: recognition and management.
    George ED; Sadovsky R
    Am Fam Physician; 1999 Apr; 59(7):1885-94. PubMed ID: 10208707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case of aggressive multiple myeloma with cleaved, multilobated, and monocytoid nuclei, and no serum monoclonal gammopathy.
    Yeh YA; Pappas AA; Flick JT; Butch AW
    Ann Clin Lab Sci; 2000 Jul; 30(3):283-8. PubMed ID: 10945569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stevens-Johnson syndrome in two patients treated with cranial irradiation and phenytoin.
    Aydin F; Cokluk C; Senturk N; Aydin K; Canturk MT; Turanli AY
    J Eur Acad Dermatol Venereol; 2006 May; 20(5):588-90. PubMed ID: 16684289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenytoin in cutaneous medicine: its uses, mechanisms and side effects.
    Scheinfeld N
    Dermatol Online J; 2003 Aug; 9(3):6. PubMed ID: 12952753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diphenylhydantoin-induced pure red cell aplasia after neurological surgery: report of two cases].
    Tanaka S; Toujou H; Tara M; Uetsuhara K
    No Shinkei Geka; 2000 Aug; 28(8):713-7. PubMed ID: 11002494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene expression profiling of plasma cell dyscrasias reveals molecular patterns associated with distinct IGH translocations in multiple myeloma.
    Mattioli M; Agnelli L; Fabris S; Baldini L; Morabito F; Bicciato S; Verdelli D; Intini D; Nobili L; Cro L; Pruneri G; Callea V; Stelitano C; Maiolo AT; Lombardi L; Neri A
    Oncogene; 2005 Apr; 24(15):2461-73. PubMed ID: 15735737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diphenylhydantoin-induced pure red cell aplasia.
    Rusia U; Malhotra P; Joshi P
    J Indian Med Assoc; 2006 Jan; 104(1):34-6. PubMed ID: 16850864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.